Peking Union Medical College Hospital: Pancreatic Neoplasms trials

The registry lists 33 Pancreatic Neoplasms studies with Peking Union Medical College Hospital as lead sponsor. 12 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 6No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer CachexiaRecruitingNCT07670286
• Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer PatientsNot yet recruitingNCT07553793Phase 1
• XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic CancerNot yet recruitingNCT07114666Not applicable
• Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic CancerRecruitingNCT06387810Phase 2
• Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer PatientsRecruitingNCT06375473
• Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer PatientRecruitingNCT06090825
• The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic CancerRecruitingNCT05802407Not applicable
• The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic CancerRecruitingNCT05802394Not applicable
• Radiographic Response to Chemotherapy in Unresected Localized Pancreatic CancerRecruitingNCT05729737
• Cross-sectional Follow-up on Digestive and Social Functions of SPNRecruitingNCT05604716
• sCD8, as a Novel Biomarker for Pancreatic CancerRecruitingNCT05500027
• The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic CancerRecruitingNCT03747588Not applicable
• Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic CancerCompletedNCT07161921
• Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic OutcomesCompletedNCT07147374
• MRD in PAAD Adjuvant TherapyActive, not recruitingNCT06867146Not applicable
• Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor PatientsCompletedNCT06659237
• Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerActive, not recruitingNCT06429904Phase 2
• 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic CancerStatus unknownNCT05875753Early Phase 1
• The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic CancerStatus unknownNCT05802420Not applicable
• Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic CancerStatus unknownNCT05689138
• Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic UltrasoundCompletedNCT05617872Not applicable
• Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic NeoplasmsStatus unknownNCT05259384Not applicable
• Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/BiopsyCompletedNCT05171517
• 25G and 22G Puncture NeedlesStatus unknownNCT05101772
• To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic UltrasoundCompletedNCT04834505
• Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic CancerStatus unknownNCT04803851Phase 1/2
• Routine Staple Line Reinforcement for Minimally Invasive Distal PancreatectomyStatus unknownNCT04663789Not applicable
• Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT03885219Phase 2
• Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerStatus unknownNCT03850769Phase 2
• The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer PatientsStatus unknownNCT03770559Not applicable
• Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in Cystic Tumors of the PancreasStatus unknownNCT03182270Not applicable
• Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph NodesStatus unknownNCT02754180Phase 2
• Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After ChemotherapyStatus unknownNCT02654288